BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2464818)

  • 1. Feulgen DNA values in Wilms' tumour in relation to prognosis.
    Oppedal BR; Glomstein A; Zetterberg A
    Pathol Res Pract; 1988 Nov; 183(6):756-60. PubMed ID: 2464818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of DNA content in childhood renal tumours.
    Kumar S; Marsden HB; Cowan RA; Barnes JM
    Br J Cancer; 1989 Feb; 59(2):291-5. PubMed ID: 2539176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of DNA content analysis and immunohistochemistry in the evaluation of the risk of unfavourable outcome in Wilms' tumours.
    Osterheld MC; Caron L; Meagher-Villemure K
    Anticancer Res; 2008; 28(2A):751-6. PubMed ID: 18507016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
    Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephroblastomas (Wilms' tumors) and special variations of nephroblastomas].
    Schmidt D
    Veroff Pathol; 1989; 133():1-174. PubMed ID: 2556868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The measurement of DNA content in Wilms' tumor and its clinical significance.
    Chen F; Li ZC; Ge RQ; Liu GH; Cai W; Zhang ZD
    J Pediatr Surg; 1994 Apr; 29(4):548-50. PubMed ID: 8014813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional DNA content heterogeneity in Wilms' tumor: incidence and potential clinical relevance.
    Yildiz I; Jaffe N; Aksoy F; el-Naggar AK
    Anticancer Res; 1994; 14(3B):1365-9. PubMed ID: 8067707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal tumours other than Wilms' tumour in the paediatric age group.
    Oesch I; Bettex M; Zimmermann A
    Z Kinderchir; 1983 Jun; 38(3):163-8. PubMed ID: 6314695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA quantitation of Wilms' tumour (nephroblastoma) using flow cytometry and image analysis.
    Gururangan S; Dorman A; Ball R; Curran B; Leader M; Breatnach F; O'Meara A
    J Clin Pathol; 1992 Jun; 45(6):498-501. PubMed ID: 1320635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
    Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
    Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometry of DNA in research on kidney tumors].
    Zubrikhina GN; Sokolova IN; Chistiakova OV
    Arkh Patol; 1989; 51(8):16-20. PubMed ID: 2554862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilms' tumor: evaluation of histological features.
    Takaoka S
    Bull Tokyo Med Dent Univ; 1977 Mar; 24(1):27-42. PubMed ID: 192480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P
    Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of the resectability of Wilms' tumors in childhood].
    Schaarschmidt K; Ritter J; Willital GH; Olesczcuk-Raschke K; Kindhäuser V; Stratmann U
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1084-90. PubMed ID: 9101787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congenital Wilms' tumors are mostly (benign) mesoblastic nephromas--significance of prenatally detected solid kidney tumors].
    Gutjahr P
    Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):124-6. PubMed ID: 1645691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
    Wadey RB; Pal N; Buckle B; Yeomans E; Pritchard J; Cowell JK
    Oncogene; 1990 Jun; 5(6):901-7. PubMed ID: 2163053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anaplastic type of Wilms' tumour].
    Vujanić GM; Aleksandrović S
    Srp Arh Celok Lek; 1990; 118(9-10):353-6. PubMed ID: 1966350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
    Ora I; van Tinteren H; Bergeron C; de Kraker J;
    Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.